FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synopsis injection 2ml pre-filled syringes (Goldshield Pharmaceuticals Ltd) 1 pre-filled disposable injection VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Zinc compound paste (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 20mg modified-release tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Stemetil 25mg suppositories (Castlemead Healthcare Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg/5ml oral solution (Rosemont Pharmaceuticals Ltd) 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nystan 500,000unit tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovonex 50micrograms/g ointment (LEO Pharma) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dutonin 200mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 50mg tablets (Unichem Plc) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul SSD dressing 10cm x 12cm (Parema) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Narcan Neonatal 40micrograms/2ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Capastat 1g powder for solution for injection vials (King Pharmaceuticals Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Advazorb dressing 5cm x 7.5cm rectangular (Advancis Medical) 1 dressing VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Neomycin 0.5% cream (Unichem Plc) 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Potter's Vegetable Cough Remover elixir (Potter's (Herbal Supplies) Ltd) 200 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nytol Herbal tablet (Haleon UK Ltd) 28 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Phenylbutazone 200mg tablets (Unichem Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phenylbutazone 200mg tablets (Essential Generics) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phenylbutazone 200mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Uvistat lipscreen SPF 30 (LPC Medical (UK) Ltd) 5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Tickly Coughs Non-Drowsy oral solution (McNeil Ltd) 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Dowelhurst Ltd) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxapram 100mg/5ml solution for injection ampoules (Goldshield Pharmaceuticals Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pentosan polysulfate sodium 100mg capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neulactil Forte syrup (JHC Healthcare Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Non-Drowsy Sudafed 12 Hour Relief 120mg tablets (Pfizer Consumer Healthcare) 12 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cosmegen Lyovac 500microgram powder for solution for injection vials (Recordati Rare Diseases UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mysoline 250mg/5ml oral suspension (Zeneca Pharma) 250 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Polyfusor DE glucose 50% solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Kilkof Expectorant oral solution (Bell,Sons & Co (Druggists) Ltd) 150 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vitlipid N Adult emulsion for injection 10ml ampoules (Waymade Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haliborange Multivitamins Plus Calcium & Iron chewable tablets (Seven Seas Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tenoxicam 20mg powder and solvent for solution for injection vials (Essential Generics Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Duragel 2% gel (SSL International Plc) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 2% gel (A A H Pharmaceuticals Ltd) 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zinc and Ichthammol cream (A A H Pharmaceuticals Ltd) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phenylbutazone 100mg tablets (Unichem Plc) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucose 50% solution for injection 500ml polyethylene bottles (A A H Pharmaceuticals Ltd) 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prochlorperazine 25mg suppositories (Special Order) 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
NiQuitin Minis Mint 1.5mg lozenges (GlaxoSmithKline Consumer Healthcare) 20 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Indapamide 1.25mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg / Indapamide 1.25mg tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane biphasic human 15/85 100units/ml suspension for injection 3ml cartridges VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insuman Comb 15 100units/ml suspension for injection 3ml cartridges (Aventis Pharma) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insulin isophane biphasic human 15/85 100units/ml suspension for injection 3ml cartridges 5 cartridge VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Insuman Comb 15 100units/ml suspension for injection 3ml cartridges (Aventis Pharma) 5 cartridge VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hydroxypropyl methylcellulose 0.32% single-use eye drops VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.32% eye drops 0.5ml unit dose preservative free 60 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.32% eye drops 0.5ml unit dose preservative free 30 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops (Nucare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops (Nucare Plc) 30 unit dose 3 x 10 unit doses VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops (Nucare Plc) 60 unit dose 6 x 10 unit doses VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 milliliter conventional release eye drops VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Dowelhurst Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Isopto Atropine 1% eye drops (Alcon Eye Care UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (A A H Pharmaceuticals Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Isopto Atropine 1% eye drops (Alcon Eye Care UK Ltd) 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Dowelhurst Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Kent Pharma (UK) Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Unichem Plc) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Martindale Pharmaceuticals Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Accord Healthcare Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Dr Reddy's Laboratories (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Necessity Supplies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Dr Reddy's Laboratories (UK) Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Necessity Supplies Ltd) 21 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% cream 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eryacne 4 gel (Galderma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Propaderm 0.025% ointment (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Propaderm 0.025% cream (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% ointment (Essential Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% ointment 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% cream (Essential Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Erythromycin 4% gel (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Erythromycin 4% gel 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Erythromycin 4% gel 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eryacne 4 gel (Galderma (UK) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% ointment (Essential Generics Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Erythromycin 4% gel (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Propaderm 0.025% ointment (GlaxoSmithKline) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Propaderm 0.025% cream (GlaxoSmithKline) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% cream (Essential Generics Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 20cm x 30cm (B.Braun Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 20cm x 30cm (B.Braun Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 20cm x 30cm (B.Braun Medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 10cm x 18cm VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 5cm x 7.5cm VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 7.5cm x 10cm VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 7.5cm x 10cm (B.Braun Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 43 of 86 Next End

This concept is not in any reference sets

Back to Start